Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders.

Ghigna MR, Reineke T, Rincé P, Schüffler P, El Mchichi B, Fabre M, Jacquemin E, Durrbach A, Samuel D, Joab I, Guettier C, Lucioni M, Paulli M, Tinguely M, Raphael M.

Pathobiology. 2013;80(2):53-9. doi: 10.1159/000339722. Epub 2012 Aug 4.

PMID:
22868923
2.

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.

Johnson LR, Nalesnik MA, Swerdlow SH.

Am J Surg Pathol. 2006 Dec;30(12):1604-12.

PMID:
17122518
4.

Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.

Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP, et al.

Transplantation. 1994 Aug 15;58(3):317-24.

PMID:
8053055
7.
8.

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.

Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM.

Transplantation. 2002 May 27;73(10):1603-10.

PMID:
12042647
9.

In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.

Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE.

Mod Pathol. 1992 May;5(3):292-302.

PMID:
1323104
10.

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.

Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):393-9. doi: 10.1111/j.1399-3062.2009.00410.x. Epub 2009 May 26.

PMID:
19497070
11.

bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.

Chetty R, Biddolph S, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A, Gatter K.

J Pathol. 1996 Nov;180(3):254-8.

PMID:
8958801
12.

Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders.

Morscio J, Dierickx D, Ferreiro JF, Herreman A, Van Loo P, Bittoun E, Verhoef G, Matthys P, Cools J, Wlodarska I, De Wolf-Peeters C, Sagaert X, Tousseyn T.

Am J Transplant. 2013 May;13(5):1305-16. doi: 10.1111/ajt.12196. Epub 2013 Mar 14.

13.

Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.

Capello D, Berra E, Cerri M, Gaidano G.

Minerva Med. 2004 Feb;95(1):53-64.

PMID:
15041926
14.

Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.

Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF.

Hum Pathol. 2001 Sep;32(9):963-9.

PMID:
11567226
15.

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.

Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.

J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):445-9.

PMID:
11698761
16.

Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.

Gärtner BC, Schäfer H, Marggraff K, Eisele G, Schäfer M, Dilloo D, Roemer K, Laws HJ, Sester M, Sester U, Einsele H, Mueller-Lantzsch N.

J Clin Microbiol. 2002 Feb;40(2):351-8. Erratum in: J Clin Microbiol 2002 Jun;40(6):2316.

17.

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R.

Am J Transplant. 2015 Oct;15(10):2665-73. doi: 10.1111/ajt.13324. Epub 2015 May 18.

18.

Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease.

Setsuda J, Teruya-Feldstein J, Harris NL, Ferry JA, Sorbara L, Gupta G, Jaffe ES, Tosato G.

Am J Pathol. 1999 Jul;155(1):257-65.

19.

Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection.

Buda A, Caforio A, Calabrese F, Fagiuoli S, Pevere S, Livi U, Naccarato R, Burra P.

Transpl Int. 2000;13 Suppl 1:S402-5.

20.

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M.

Transpl Immunol. 2007 Apr;17(3):203-10. Epub 2006 Nov 29.

PMID:
17331848

Supplemental Content

Support Center